The role of brain vasculature in neurodegenerative disorders (Q59784797)

2

0 references

Arthur W. Toga

4

object named as

Arthur W Toga

0 references

author name string

Melanie D Sweeney

1

0 references

Axel Montagne

The Neurovascular Unit Coming of Age: A Journey through Neurovascular Coupling in Health and Disease

3

0 references

language of work or name

English

0 references

publication date

October 2018

0 references

published in

Nature Neuroscience

0 references

volume

21

0 references

issue

10

0 references

page(s)

1318-1331

0 references

cites work

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Cerebral blood flow regulation and neurovascular dysfunction in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Pericyte structure and distribution in the cerebral cortex revealed by high-resolution imaging of transgenic mice

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Establishment and Dysfunction of the Blood-Brain Barrier

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Pericytes of the neurovascular unit: key functions and signaling pathways.

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Alzheimer's disease: A matter of blood-brain barrier dysfunction?

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

A molecular atlas of cell types and zonation in the brain vasculature

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Mfsd2a is a transporter for the essential omega-3 fatty acid docosahexaenoic acid

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Mfsd2a is critical for the formation and function of the blood-brain barrier

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Brain structure. Cell types in the mouse cortex and hippocampus revealed by single-cell RNA-seq

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Capillary pericytes express α-smooth muscle actin, which requires prevention of filamentous-actin depolymerization for detection.

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Pericyte degeneration leads to neurovascular uncoupling and limits oxygen supply to brain.

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Bidirectional control of CNS capillary diameter by pericytes.

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Capillary pericytes regulate cerebral blood flow in health and disease

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Astrocytes mediate neurovascular signaling to capillary pericytes but not to arterioles.

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Glial Cell Calcium Signaling Mediates Capillary Regulation of Blood Flow in the Retina.

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Pericytes in capillaries are contractile in vivo, but arterioles mediate functional hyperemia in the mouse brain

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Granular Layer Neurons Control Cerebellar Neurovascular Coupling Through an NMDA Receptor/NO-Dependent System.

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Regional Blood Flow in the Normal and Ischemic Brain Is Controlled by Arteriolar Smooth Muscle Cell Contractility and Not by Capillary Pericytes

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Erythrocytes Are Oxygen-Sensing Regulators of the Cerebral Microcirculation

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Coupling mechanism and significance of the BOLD signal: a status report

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Capillary K -sensing initiates retrograde hyperpolarization to increase local cerebral blood flow

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

The cortical angiome: an interconnected vascular network with noncolumnar patterns of blood flow

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Purinergic control of vascular tone in the retina

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Cell type specificity of neurovascular coupling in cerebral cortex.

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Production of 20-HETE and its role in autoregulation of cerebral blood flow

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Mechanisms Mediating Functional Hyperemia in the Brain

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Muscarinic receptor knockout mice confirm involvement of M3 receptor in endothelium-dependent vasodilatation in mouse arteries

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Cholinergic dilation of cerebral blood vessels is abolished in M(5) muscarinic acetylcholine receptor knockout mice

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Pericytes are required for blood-brain barrier integrity during embryogenesis

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Pericytes Control Key Neurovascular Functions and Neuronal Phenotype in the Adult Brain and during Brain Aging

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Pericytes regulate the blood-brain barrier

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Central nervous system pericytes in health and disease

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Regional early and progressive loss of brain pericytes but not vascular smooth muscle cells in adult mice with disrupted platelet-derived growth factor receptor-β signaling

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Ephrin-B2 controls cell motility and adhesion during blood-vessel-wall assembly

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Apolipoprotein E controls cerebrovascular integrity via cyclophilin A.

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Frizzled Receptors in Development and Disease

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Wnt/beta-catenin signaling controls development of the blood-brain barrier

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Early role of vascular dysregulation on late-onset Alzheimer's disease based on multifactorial data-driven analysis

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Brain imaging of neurovascular dysfunction in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Blood-brain barrier breakdown in the aging human hippocampus

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Relation of cerebral vessel disease to Alzheimer's disease dementia and cognitive function in elderly people: a cross-sectional study

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the National Alzheimer's Coordinating Centre

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

The pathobiology of vascular dementia

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Interactive Associations of Vascular Risk and β-Amyloid Burden With Cognitive Decline in Clinically Normal Elderly Individuals: Findings From the Harvard Aging Brain Study

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Cerebrospinal fluid biomarkers of neurovascular dysfunction in mild dementia and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Cerebral hypoperfusion and clinical onset of dementia: the Rotterdam Study

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Voxel-level comparison of arterial spin-labeled perfusion MRI and FDG-PET in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

The Utility of Cerebral Blood Flow as a Biomarker of Preclinical Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Effect of mild cognitive impairment and APOE genotype on resting cerebral blood flow and its association with cognition

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Perfusion abnormalities in mild cognitive impairment and mild dementia in Alzheimer's disease measured by pulsed arterial spin labeling MRI.

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Mild cognitive impairment and alzheimer disease: patterns of altered cerebral blood flow at MR imaging

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Distinct cerebral perfusion patterns in FTLD and AD

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Cortical and subcortical cerebrovascular resistance index in mild cognitive impairment and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Neurovascular unit impairment in early Alzheimer's disease measured with magnetic resonance imaging.

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Simultaneous measurement of arterial transit time, arterial blood volume, and cerebral blood flow using arterial spin-labeling in patients with Alzheimer disease

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Lower cerebral blood flow is associated with impairment in multiple cognitive domains in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Aberrant pattern of regional cerebral blood flow in Alzheimer's disease: a voxel-wise meta-analysis of arterial spin labeling MR imaging studies

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Reduced Cerebral Blood Flow in Mild Cognitive Impairment Assessed Using Phase-Contrast MRI.

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Arterial spin labeling imaging reveals widespread and Aβ-independent reductions in cerebral blood flow in elderly apolipoprotein epsilon-4 carriers

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

APOE epsilon4 genotype and longitudinal changes in cerebral blood flow in normal aging

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Impaired cerebral autoregulation and vasomotor reactivity in sporadic Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Forebrain-dominant deficit in cerebrovascular reactivity in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Capillary cerebral amyloid angiopathy in Alzheimer's disease: association with allocortical/hippocampal microinfarcts and cognitive decline.

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Reduced cerebrovascular reactivity in young adults carrying the APOE ε4 allele

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Apolipoprotein E, carbon dioxide vasoreactivity, and cognition in older adults: effect of hypertension

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Differential regional dysfunction of the hippocampal formation among elderly with memory decline and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Functional magnetic resonance imaging detection of vascular reactivity in cerebral amyloid angiopathy

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

SOD1 rescues cerebral endothelial dysfunction in mice overexpressing amyloid precursor protein

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Age-dependent neurovascular dysfunction and damage in a mouse model of cerebral amyloid angiopathy.

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Pericyte degeneration causes white matter dysfunction in the mouse central nervous system.

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Human apolipoprotein E ɛ4 expression impairs cerebral vascularization and blood-brain barrier function in mice

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Blood-Brain Barrier Leakage in Patients with Early Alzheimer Disease

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Subtle blood-brain barrier leakage rate and spatial extent: Considerations for dynamic contrast-enhanced MRI.

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Multiple microbleeds are related to cerebral network disruptions in patients with early Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Cerebral microbleeds in early Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Cerebral microbleeds: different prevalence, topography, and risk factors depending on dementia diagnosis—the Karolinska Imaging Dementia Study

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Cerebral microbleeds as a biomarker in Alzheimer's disease? A review in the field

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Prevalence and risk factors of cerebral microbleeds: the Rotterdam Scan Study

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Incidence of cerebral microbleeds in preclinical Alzheimer disease

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

High prevalence of cerebral microbleeds at 7Tesla MRI in patients with early Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Prevalence and topography of small hypointense foci suggesting microbleeds on 3T susceptibility-weighted imaging in various types of dementia

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Interaction between cerebrovascular disease and Alzheimer pathology.

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

A Cross-Validation of FDG- and Amyloid-PET Biomarkers in Mild Cognitive Impairment for the Risk Prediction to Dementia due to Alzheimer's Disease in a Clinical Setting

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Amyloid and metabolic positron emission tomography imaging of cognitively normal adults with Alzheimer's parents

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer's disease, and other dementias

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Posterior cingulate glucose metabolism, hippocampal glucose metabolism, and hippocampal volume in cognitively normal, late-middle-aged persons at 3 levels of genetic risk for Alzheimer disease

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD.

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Precuneus and Cingulate Cortex Atrophy and Hypometabolism in Patients with Alzheimer's Disease and Mild Cognitive Impairment: MRI and (18)F-FDG PET Quantitative Analysis Using FreeSurfer.

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Clinical and biomarker changes in dominantly inherited Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI.

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Comparing predictors of conversion and decline in mild cognitive impairment

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

GLUT1 reductions exacerbate Alzheimer's disease vasculo-neuronal dysfunction and degeneration

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Blood-Brain Glucose Transfer in Alzheimer's disease: Effect of GLP-1 Analog Treatment

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Diminished glucose transport in Alzheimer's disease: dynamic PET studies

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

GLUT-1 Expression in the Cerebra of Patients with Alzheimer’s Disease

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Reduced glucose transporter at the blood-brain barrier and in cerebral cortex in Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Decreased concentrations of GLUT1 and GLUT3 glucose transporters in the brains of patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Immunolabelling of hippocampal microvessel glucose transporter protein is reduced in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Small Molecule PET Tracers for Transporter Imaging

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

P-glycoprotein deficiency at the blood-brain barrier increases amyloid-beta deposition in an Alzheimer disease mouse model

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Activity of P-Glycoprotein, a β-Amyloid Transporter at the Blood-Brain Barrier, Is Compromised in Patients with Mild Alzheimer Disease.

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Blood-brain barrier P-glycoprotein function in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Pericyte loss influences Alzheimer-like neurodegeneration in mice.

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Fibrin deposition accelerates neurovascular damage and neuroinflammation in mouse models of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

LRP/amyloid beta-peptide interaction mediates differential brain efflux of Abeta isoforms.

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

A multimodal RAGE-specific inhibitor reduces amyloid β-mediated brain disorder in a mouse model of Alzheimer disease

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Selective expression of presenilin 1 in neural progenitor cells rescues the cerebral hemorrhages and cortical lamination defects in presenilin 1-null mutant mice

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Tau depletion prevents progressive blood-brain barrier damage in a mouse model of tauopathy

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

The APOE4 allele shows opposite sex bias in microbleeds and Alzheimer's disease of humans and mice

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Arterial spin labelling reveals an abnormal cerebral perfusion pattern in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Arterial spin labelling detects posterior cortical hypoperfusion in non-demented patients with Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Complex relationships between cerebral blood flow and brain atrophy in early Huntington's disease.

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Quantification of perfusion and permeability in multiple sclerosis: dynamic contrast-enhanced MRI in 3D at 3T.

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Cortical Perfusion Alteration in Normal-Appearing Gray Matter Is Most Sensitive to Disease Progression in Relapsing-Remitting Multiple Sclerosis

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Widespread cerebral haemodynamics disturbances occur early in amyotrophic lateral sclerosis.

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Gray matter perfusion correlates with disease severity in ALS.

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Structural and physiological neurovascular changes in idiopathic Parkinson's disease and its clinical phenotypes

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Cerebral blood flow modulation insufficiency in brain networks in multiple sclerosis: A hypercapnia MRI study

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Cerebrovascular and blood-brain barrier impairments in Huntington's disease: Potential implications for its pathophysiology

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Quantitative measurement of blood-brain barrier permeability in human using dynamic contrast-enhanced MRI with fast T1 mapping

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Abnormal blood-brain barrier permeability in normal appearing white matter in multiple sclerosis investigated by MRI

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Evolution of the blood-brain barrier in newly forming multiple sclerosis lesions

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Cerebral microbleeds in patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Characterization of cerebral microbleeds in idiopathic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

The prevalence and risk factors of cerebral microbleeds in patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Iron accumulation in deep cortical layers accounts for MRI signal abnormalities in ALS: correlating 7 tesla MRI and pathology.

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Blood-brain barrier dysfunction in parkinsonian midbrain in vivo

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Imaging matrix metalloproteinase activity in multiple sclerosis as a specific marker of leukocyte penetration of the blood-brain barrier.

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Neurovascular dysfunction and neurodegeneration in dementia and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Neurovascular regulation in the normal brain and in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Ultra-sensitive molecular MRI of cerebrovascular cell activation enables early detection of chronic central nervous system disorders.

1 reference

https://api.crossref.org/works/10.1038/S41593-018-0234-X

7 January 2021

Diminished glucose transport and phosphorylation in Alzheimer's disease determined by dynamic FDG-PET.

1 reference

12 December 2020

Functional MR imaging in Alzheimer's disease during memory encoding.

1 reference

12 December 2020

Hypometabolism exceeds atrophy in presymptomatic early-onset familial Alzheimer's disease.

1 reference

12 December 2020

Astrocytic laminin regulates pericyte differentiation and maintains blood brain barrier integrity.

1 reference

12 December 2020

Abnormal Cerebrovascular Reactivity in Patients with Parkinson's Disease

1 reference

12 December 2020

Divergent regional patterns of cerebral hypoperfusion and gray matter atrophy in mild cognitive impairment patients

1 reference

12 December 2020

Lower cerebral blood flow in subjects with Alzheimer's dementia, mild cognitive impairment, and subjective cognitive decline using two-dimensional phase-contrast magnetic resonance imaging

1 reference

12 December 2020